Evidence map›Paper›PMID 25670736›Full record

ReviewFEMS microbiology reviews2015

Mechanisms of group A Streptococcus resistance to reactive oxygen species.

Anna Henningham, Simon Döhrmann, Victor Nizet, Jason N Cole

Open access · bronzeAbstract readReview
In one paragraph

Review in FEMS microbiology reviews, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
7.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 89 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. EmergentInfection and immunity · 2024
    Article
  12. Article
  13. Interplay between group AMicrobiology and molecular biology reviews : MMBR · 2024
    Review
  14. Immunomodulating Enzymes fromMicroorganisms · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Neutrophils inMicroorganisms · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Anna HenninghamDepartment of Pediatrics, University of California San Diego, La Jolla, CA 92093, USA The School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072, Australia The Australian Infectious Diseases Research Centre, The University of Queensland, St Lucia, QLD 4072, Australia.
Simon DöhrmannDepartment of Pediatrics, University of California San Diego, La Jolla, CA 92093, USA.
Victor NizetDepartment of Pediatrics, University of California San Diego, La Jolla, CA 92093, USA Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA 92093, USA Rady Children's Hospital, San Diego, CA 92123, USA.
Jason N ColeDepartment of Pediatrics, University of California San Diego, La Jolla, CA 92093, USA The School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072, Australia The Australian Infectious Diseases Research Centre, The University of Queensland, St Lucia, QLD 4072, Australia jncole@ucsd.edu.
University of California, San Diego · US

Funding

GAS Switch from Colonizing Bacterium to Invasive PathogenR01AI077780 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NIZET, VICTOR · 2008 to 2019
$3.8M
Mechanisms of the M protein in group A Streptococcus virulenceR01AI096837 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GHOSH, PARTHO, NIZET, VICTOR · 2011 to 2015
$2.7M
CATHELICIDINS--A MOLECULAR BACTERIOLOGIC APPROACHR21AI048176 · NIAID · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI GALLO, RICHARD L · 2000 to 2001
$420k
NIAID NIH HHS AI077780NIAID NIH HHS AI48176NIAID NIH HHS R01 AI077780NIAID NIH HHS R01 AI096837
6 · The paper itself

Abstract

Streptococcus pyogenes, also known as group A Streptococcus (GAS), is an exclusively human Gram-positive bacterial pathogen ranked among the 'top 10' causes of infection-related deaths worldwide. GAS commonly causes benign and self-limiting epithelial infections (pharyngitis and impetigo), and less frequent severe invasive diseases (bacteremia, toxic shock syndrome and necrotizing fasciitis). Annually, GAS causes 700 million infections, including 1.8 million invasive infections with a mortality rate of 25%. In order to establish an infection, GAS must counteract the oxidative stress conditions generated by the release of reactive oxygen species (ROS) at the infection site by host immune cells such as neutrophils and monocytes. ROS are the highly reactive and toxic byproducts of oxygen metabolism, including hydrogen peroxide (H2O2), superoxide anion (O2•(-)), hydroxyl radicals (OH•) and singlet oxygen (O2*), which can damage bacterial nucleic acids, proteins and cell membranes. This review summarizes the enzymatic and regulatory mechanisms utilized by GAS to thwart ROS and survive under conditions of oxidative stress.

Indexed as

Host-Pathogen InteractionsHumansOxidative StressReactive Oxygen SpeciesStreptococcal InfectionsStreptococcusReactive Oxygen SpeciesGroup A Streptococcusinnate immunityoxidative stress resistancereactive oxygen speciesStreptococcus pyogenesvirulence

Identifiers

PMID25670736
PMCPMC4487405
OpenAlexW2133550699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.